Growth in new daily cancer patients and radiation treatment and diagnostic procedures powered revenue for radiation therapy center operator US Oncology of Houston in the first quarter of 2010 (end-March 31).
Revenue advanced 5% to $880.5 million, compared with $842.6 million in the first quarter of 2009. Pharmaceutical services led the company with a 7% increase in revenue to $618.2 million in the first quarter, compared with $577.6 million in the same quarter a year ago.
US Oncology also posted a net loss of $100,000, compared with net income of $1 million in the same quarter of 2009. The company blamed the net loss on incremental interest expense related to the refinancing of senior notes and a line of credit in the second quarter of 2009.
Related Reading
Nucletron outfits US Oncology, July 24, 2009
US Oncology adds to revenue in 2008, February 26, 2009
US Oncology posts mixed Q3, November 6, 2008
RTOG, US Oncology to increase access to clinical trials, October 16, 2008
US Oncology names Smith to VP post, August 26, 2008
Copyright © 2010 AuntMinnie.com
